Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study
BackgroundFluoroquinolones (FQs) are the most important second-line anti-tuberculosis (anti-TB) drugs, primarily used for the treatment of multidrug- or rifampicin-resistant TB (MDR/RR-TB). However, FQs are also commonly used to treat other bacterial infections. There are few published data on the r...
Main Authors: | Yangyi Zhang, Yuan Jiang, Chenlei Yu, Jing Li, Xuhui Shen, Qichao Pan, Xin Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.990894/full |
Similar Items
-
Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study
by: Minjuan Li, et al.
Published: (2024-12-01) -
Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis
by: Jing Li, et al.
Published: (2014-01-01) -
Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01) -
Evaluation of the resistance of Mycobacterium tuberculosis to rifampicin at the regional hospital center of Maradi, Niger Republic
by: Ousmane Abdoulaye, et al.
Published: (2022-01-01) -
High degree of fluoroquinolone resistance among extrapulmonary tuberculosis patients at a tertiary care center in North India
by: Jigyasa Chaubey, et al.
Published: (2020-01-01)